📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir. (2017)

First Author: Jose S

Attributed to: Continued follow-up of the United Kingdom Collaborative HIV Cohort (UK CHIC) and the UK HIV Drug Resistance Database (UK HDRD), 2014-2019 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/qad.0000000000001353

PubMed Identifier: 28121667

Publication URI: http://europepmc.org/abstract/MED/28121667

Type: Journal Article/Review

Volume: 31

Parent Publication: AIDS (London, England)

Issue: 4

ISSN: 0269-9370